These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10146219)

  • 1. Impact of DRGs on the medical profession.
    Hervis RM
    Clin Lab Sci; 1993; 6(3):183-5. PubMed ID: 10146219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in MS-DRG assignment and hospital reimbursement as a result of Centers for Medicare & Medicaid changes in payment for hospital-acquired conditions: is it coding or quality?
    McNutt R; Johnson TJ; Odwazny R; Remmich Z; Skarupski K; Meurer S; Hohmann S; Harting B
    Qual Manag Health Care; 2010; 19(1):17-24. PubMed ID: 20042930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. After the revolution: DRGs at age 30.
    Quinn K
    Ann Intern Med; 2014 Mar; 160(6):426-9. PubMed ID: 24723081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Components of Medicare reimbursement.
    Malatestinic W; Braun L; Jorgenson JA; Eskew J
    Am J Health Syst Pharm; 2003 Nov; 60(21 Suppl 6):S3-7. PubMed ID: 14619126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and performance of different DRG classification systems for neonatal medicine.
    Muldoon JH
    Pediatrics; 1999 Jan; 103(1 Suppl E):302-18. PubMed ID: 9917473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2007 rates; fiscal year 2007 occupational mix adjustment to wage index; health care infrastructure improvement program; selection criteria of loan program for qualifying hospitals engaged in cancer-related health care and forgiveness of indebtedness; and exclusion of vendor purchases made under the competitive acquisition program (CAP) for outpatient drugs and biologicals under part B for the purpose of calculating the average sales price (ASP). Final rules and interim final rule with comment period.
    Centers for Medicare and Medicaid Services (CMS), HHS
    Fed Regist; 2006 Aug; 71(160):47869-8351. PubMed ID: 16921666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in patient routine costliness in U.S. psychiatric facilities.
    Cromwell J; Drozd EM; Gage B; Maier J; Richter E; Goldman HH
    J Ment Health Policy Econ; 2005 Mar; 8(1):15-28. PubMed ID: 15870482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of classification and payment system of in patient hospital admissions in the United States: introduction of Medicare Severity Diagnosis-Related Groups (MS-DRGs) and the Present On Admission (POA) indicator].
    Maurici M; Rosati E
    Ig Sanita Pubbl; 2007; 63(6):691-701. PubMed ID: 18216884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis-related Groups and Hospital Inpatient Federal Reimbursement.
    Rimler SB; Gale BD; Reede DL
    Radiographics; 2015 Oct; 35(6):1825-34. PubMed ID: 26466189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do older Medicare patients cost hospitals more? Evidence from an academic medical center.
    Rosenthal GE; Landefeld CS
    Arch Intern Med; 1993 Jan; 153(1):89-96. PubMed ID: 8422203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Part 2, Responding to PPS. Development and interpretation of the diagnosis-related groups (DRGs).
    Averill RF; Kalison MJ
    Healthc Financ Manage; 1984 Feb; 38(2):72-4, 78-84. PubMed ID: 10315503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the impact of Medicare and Medicaid prospective payment on utilization of Philadelphia area hospitals.
    Smith DB; Pickard R
    Health Serv Res; 1986 Oct; 21(4):529-46. PubMed ID: 3095267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The history and evolution of hospital payment systems: how did we get here?
    Whetsell GW
    Nurs Adm Q; 1999; 23(4):1-15. PubMed ID: 10711138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of a fixed-fee reimbursement system introduced by the Federal Government on laboratory testing in the United States.
    Takemura Y; Beck JR
    Rinsho Byori; 1999 Jan; 47(1):1-10. PubMed ID: 10067359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interhospital differences in severity of illness. Problems for prospective payment based on diagnosis-related groups (DRGs).
    Horn SD; Bulkley G; Sharkey PD; Chambers AF; Horn RA; Schramm CJ
    N Engl J Med; 1985 Jul; 313(1):20-4. PubMed ID: 3923354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of reimbursement changes for intracoronary stents on providers and Medicare.
    Vaitkus PT
    Am J Manag Care; 1998 Aug; 4(8):1097-102. PubMed ID: 10182885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost containment, DRGs, and the ethics of health care. Ethical perspectives on prospective payment.
    Dougherty CJ
    Hastings Cent Rep; 1989; 19(1):5-11. PubMed ID: 2497082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Will payment based on diagnosis-related groups control hospital costs?
    Wennberg JE; McPherson K; Caper P
    N Engl J Med; 1984 Aug; 311(5):295-300. PubMed ID: 6429534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost containment (DRGs): a new source for litigation?
    Zaremski M; Rehm J
    Health Matrix; 1985; 3(2):24-7. PubMed ID: 10311246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Data quality. An illustration of its potential impact upon a diagnosis-related group's case mix index and reimbursement.
    Doremus HD; Michenzi EM
    Med Care; 1983 Oct; 21(10):1001-11. PubMed ID: 6418985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.